Potassium
Potassium Chloride
The FDA lists this product in 60 strengths and forms.
Indications
Potassium Chloride is indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis, in patients for whom dietary management with potassium-rich foods or diuretic dose reduction are insufficient. Potassium Chloride is indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis, in patients for whom dietary management with potassium-rich foods or diuretic dose reduction are insufficient.
( 1 )
Contraindications
Potassium chloride is contraindicated in patients on potassium sparing diuretics. Concomitant use with potassium sparing diuretics. ( 4 )
Warnings and precautions
Gastrointestinal Irritation : Dilute before use, take with meals ( 5.1 )
5.1Gastrointestinal Irritation
May cause gastrointestinal irritation if administered undiluted. Increased dilution of the solution and taking with meals may reduce gastrointestinal irritation [see Dosage and Administration ( 2.1 )] .
Interactions
Potassium sparing diuretics: Avoid concomitant use ( 7.1 ) Renin angiotensin-aldosterone inhibitors: Monitor for hyperkalemia ( 7.2 ) Nonsteroidal Anti-Inflammatory drugs: Monitor for hyperkalemia ( 7.3 )
7.1Potassium-Sparing Diuretics Use
with potassium-sparing diuretics can produce severe hyperkalemia. Avoid concomitant use.
7.2Renin-Angiotensin-Aldosterone System Inhibitors
Drugs that inhibit the renin-angiotensin-aldosterone inhibitors system (RAAS) including angiotensin converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), spironolactone, eplerenone, or aliskiren produce potassium retention by inhibiting aldosterone production. Closely monitor potassium in patients receiving concomitant RAAS therapy.
7.3
At a glance
- Brand name
- Potassium Chloride
- Drug class
- Potassium, Electrolyte solutions
- Route
- Oral
- Dosage form
- Solution
- Applicant
- Tris Pharma Inc
- Status
- Discontinued
- FDA approval
- 26 Jan 2022
- Application
- ANDA214076-001
- RxCUI
- 8591



